Page last updated: 2024-11-02

oxophenylarsine and African Sleeping Sickness

oxophenylarsine has been researched along with African Sleeping Sickness in 2 studies

oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fueyo González, FJ1
Ebiloma, GU1
Izquierdo García, C1
Bruggeman, V1
Sánchez Villamañán, JM1
Donachie, A1
Balogun, EO1
Inaoka, DK1
Shiba, T1
Harada, S1
Kita, K1
de Koning, HP1
Dardonville, C1
BAKER, JR1

Other Studies

2 other studies available for oxophenylarsine and African Sleeping Sickness

ArticleYear
Conjugates of 2,4-Dihydroxybenzoate and Salicylhydroxamate and Lipocations Display Potent Antiparasite Effects by Efficiently Targeting the Trypanosoma brucei and Trypanosoma congolense Mitochondrion.
    Journal of medicinal chemistry, 2017, 02-23, Volume: 60, Issue:4

    Topics: Cell Line; Drug Discovery; Humans; Hydroxybenzoates; Membrane Potential, Mitochondrial; Mitochondria

2017
The curative power of 4-(2:6-diaminopyrimidin-4-ylamino) phenylarsine oxide (compound 12,065) in infections of Trypanosoma rhodesiense in laboratory animals.
    British journal of pharmacology and chemotherapy, 1958, Volume: 13, Issue:4

    Topics: Animals; Animals, Laboratory; Arsenicals; Humans; Mice; Rats; Trypanosoma brucei rhodesiense; Trypan

1958